Atwood & Palmer’s Pfizer PFE Stock Holding History

Atwood & Palmer’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$239K	Sell	9,929 -104	-1%	-$2.72K	0.01%	155
2026 Q1	$282K	Buy	10,033 +104	+1%	+$2.77K	0.02%	144
2025 Q4	$247K	Hold	9,929	–	–	0.01%	144
2025 Q3	$253K	Hold	9,929	–	–	0.01%	145
2025 Q2	$241K	Sell	9,929 -610	-6%	-$14.2K	0.02%	143
2025 Q1	$267K	Sell	10,539 -3,400	-24%	-$89K	0.02%	133
2024 Q4	$370K	Sell	13,939 -2,000	-13%	-$54.3K	0.03%	122
2024 Q3	$461K	Hold	15,939	–	–	0.03%	112
2024 Q2	$446K	Sell	15,939 -350	-2%	-$9.64K	0.03%	112
2024 Q1	$452K	Sell	16,289 -4,210	-21%	-$117K	0.03%	110
2023 Q4	$590K	Sell	20,499 -400	-2%	-$12.1K	0.05%	101
2023 Q3	$693K	Buy	20,899 +1,500	+8%	+$53K	0.06%	90
2023 Q2	$712K	Buy	19,399 +1,600	+9%	+$62.3K	0.06%	97
2023 Q1	$726K	Hold	17,799	–	–	0.07%	89
2022 Q4	$912K	Hold	17,799	–	–	0.08%	92
2022 Q3	$779K	Hold	17,799	–	–	0.08%	93
2022 Q2	$933K	Sell	17,799 -1,490	-8%	-$75.9K	0.09%	81
2022 Q1	$999K	Sell	19,289 -4,200	-18%	-$218K	0.09%	82
2021 Q4	$1.39M	Sell	23,489 -20	-0.1%	-$991	0.12%	75
2021 Q3	$1.01M	Buy	23,509 +350	+2%	+$15.5K	0.09%	79
2021 Q2	$907K	Sell	23,159 -1,816	-7%	-$70.6K	0.08%	82
2021 Q1	$905K	Buy	24,975 +1,317	+6%	+$46.8K	0.09%	81
2020 Q4	$871K	Buy	23,658 +379	+2%	+$13.9K	0.09%	79
2020 Q3	$811K	Hold	23,279	–	–	0.1%	74
2020 Q2	$722K	Hold	23,279	–	–	0.1%	78
2020 Q1	$721K	Hold	23,279	–	–	0.11%	75
2019 Q4	$865K	Hold	23,279	–	–	0.11%	71
2019 Q3	$794K	Hold	23,279	–	–	0.11%	73
2019 Q2	$957K	Sell	23,279 -168	-0.7%	-$6.67K	0.13%	70
2019 Q1	$945K	Hold	23,447	–	–	0.13%	67
2018 Q4	$971K	Buy	23,447 +4,007	+21%	+$166K	0.15%	67
2018 Q3	$813K	Sell	19,440 -73	-0.4%	-$2.81K	0.11%	73
2018 Q2	$672K	Buy	19,513 +73	+0.4%	+$2.5K	0.09%	76
2018 Q1	$655K	Hold	19,440	–	–	0.09%	74
2017 Q4	$668K	Sell	19,440 -3,044	-14%	-$104K	0.09%	76
2017 Q3	$762K	Sell	22,484 -145	-0.6%	-$4.66K	0.11%	74
2017 Q2	$721K	Sell	22,629 -494	-2%	-$15.6K	0.11%	74
2017 Q1	$750K	Buy	23,123 +2,108	+10%	+$66.5K	0.12%	70
2016 Q4	$648K	Sell	21,015 -10,646	-34%	-$325K	0.12%	71
2016 Q3	$1.02M	Hold	31,661	–	–	0.18%	61
2016 Q2	$1.06M	Hold	31,661	–	–	0.19%	62
2016 Q1	$890K	Buy	31,661 +105	+0.3%	+$3K	0.16%	67
2015 Q4	$966K	Hold	31,556	–	–	0.18%	70
2015 Q3	$940K	Buy	31,556 +146	+0.5%	+$4.68K	0.18%	69
2015 Q2	$999K	Hold	31,410	–	–	0.18%	73
2015 Q1	$1.04M	Buy	31,410 +434	+1%	+$13.8K	0.19%	72
2014 Q4	$916K	Sell	30,976 -3,633	-10%	-$104K	0.17%	70
2014 Q3	$973K	Buy	34,609 +13,327	+63%	+$374K	0.18%	68
2014 Q2	$599K	Sell	21,282 -14,398	-40%	-$410K	0.16%	78
2014 Q1	$1.09M	Hold	35,680	–	–	0.25%	46
2013 Q4	$1.04M	Buy	35,680 +1,412	+4%	+$41.1K	0.26%	46
2013 Q3	$934K	Hold	34,268	–	–	0.26%	47
2013 Q2	$911K	Buy	+34,268	New	+$947K	0.25%	47

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Atwood & Palmer's PFE Position: Q2 2026 in Review

Atwood & Palmer reduced its Pfizer (PFE) stake by 1% in Q2 2026, selling an estimated $2.72K and leaving 9,929 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #155.

Atwood & Palmer first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.39M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Atwood & Palmer held 9,929 shares of Pfizer worth $239K as of Q2 2026.
Atwood & Palmer sold 104 Pfizer shares in Q2 2026, an estimated $2.72K.
Pfizer made up 0.01% of Atwood & Palmer's portfolio in Q2 2026, its #155 holding.
Atwood & Palmer first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Atwood & Palmer's Pfizer position peaked at $1.39M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.